Table 1.
Baseline characteristics of included studies
| First author and year | Country | Study design | Sample Size | Age(years) | Assessment of exposure | Outcome | Assessment of outcome |
|---|---|---|---|---|---|---|---|
| Toh 2009 [24] | USA and Canada | retrospective cohort study | 5731 | < 25(18.9%) |
Telephone interview |
GH/PE | Self-reported |
| Katon 2012 [13] | USA | prospective study | 1656 | ≥15 years | Self-report | GH | ICD-9 diagnoses |
| Palmsten 2012 [33] | Canada | retrospective cohort study | 69,448 | Median age was 31 | pharmacy dispensing record | PE | ICD-9 |
| De Vera 2012 [17] | Canada | case–control study | 13,376 | Mean age was 27.3 | Prescription Drug File | GH | ICD-9 |
| Palmsten 2013 [39] | Canada | prospective cohort study | 85,767 | Median age was 23–27 | medical records | PE | ICD-9CM diagnosis code |
| Avalos 2015 [23] | USA | retrospective cohort study | 18,134 | 18 years and older | electronic medical records | PE | ICD-9CM diagnosis code |
| Malm 2015 [18] | Finland | prospective study study | 25,381 | ≤40 years | Drug Reimbursement Register | GH | Medical Birth Register |
| De Ocampo 2016 [62] | USA and Canada | retrospective cohort study | 3471 | Mean age was 32.0 for unexposed | interview | GH/PE | Self-reported |
| Lupattelli 2017 [26] | Norway | prospective cohort study | 5745 | Mean age was 30 for exposed | record | PE | ICD-9CM diagnosis code |
| Yonkers 2017 [22] | USA | retrospective cohort study | 2654 | ≥35(26.6%) | Telephone interview | GH | Medial records |
| Zakiyah 2018 [11] | Netherlands | retrospective cohort study | 28,020 | Mean age was 31.1 for exposed | The prescription database IADB | GH | Dutch Society of Obstetrics and Gynaecology |
| Bernard 2019 [27] | Canada |
prospective cohort study |
6761 | 18 years and older | record | PE | ICD-9CM diagnosis code |
| Huybrechts 2020 [14] | USA | cohort study | 1.3 to 4.1 million | 18–55 |
outpatient prescription |
PE | ICD-9 diagnostic |
| Tran 2021 [6] | Netherlands | retrospective cohort study | 94,788 | ≥35(11.61%) | Netherlands Perinatal Registry and the PHARMO Database | PE | medical records |
| Yang 2021 [61] | Taiwan, China | retrospective cohort study | 5664 | Mean age was 31.3 | prescription drug utilization of Health and Welfare Database | GH/PE | ICD-9CM diagnosis code |
| Galbally 2023 [9] | Australia | retrospective cohort study | 229 | Mean age was 32 |
Mercy Pregnancy Emotional Wellbeing Study |
GH | Australian Guidelines |
| Benevent 2023 [25] | France | retrospective cohort study | 143,391 | Mean age was 30.5 for unexposed | prescription drug utilization of EFEMERIS database | GH/PE | Medical records |
SSRIs selective serotonin reuptake inhibitors, SNRIs selective serotonin-norepinephrine reuptake inhibitors, TCAs tricyclic antidepressants, GH/PE gestational hypertension or preeclampsia